Your session is about to expire
← Back to Search
End-of-Life Conversation Game for Cancer
N/A
Recruiting
Led By Lauren Van Scoy, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient with Cancer: Be an individual diagnosed with a solid tumor cancer (e.g., breast, colon, lung, melanoma, head and neck, or genitourinary/prostate cancer) as verified by primary oncologist or is the chosen caregiver for a participant with those cancers
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to up to two years after participation in research event
Awards & highlights
Summary
This trial aims to see if a game called "Hello" can help individuals with different types of cancer and their loved ones talk about end-of-life care planning. Participants will play the game and then answer
Who is the study for?
This trial is for individuals with various solid cancers such as breast, lung, and colorectal cancer. Participants will be from Penn State Health clinics who are interested in advance care planning. They should be willing to answer questionnaires, play a game designed to facilitate end-of-life conversations, join a focus group discussion, and do a follow-up interview.
What is being tested?
The study tests the 'Hello for Cancer' game against the 'Table Topics' game to see if they help in advance care planning. It checks how these games affect healthcare usage like hospital stays or emergency visits and explores necessary changes for using Hello in cancer populations.
What are the potential side effects?
Since this trial involves playing conversation games rather than medical treatments, traditional side effects associated with medications are not expected. However, participants may experience emotional discomfort discussing end-of-life topics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with a solid tumor cancer or am caring for someone who has.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to up to two years after participation in research event
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to up to two years after participation in research event
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Healthcare Utilization
Perceptions of modified intervention
Secondary study objectives
Acceptability of Intervention Measure
Advance Care Planning Engagement Measure
Advance Care Planning Surrogate Decision Maker Engagement Measure
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Hello for Cancer gameExperimental Treatment1 Intervention
For this arm, individuals will play the modified Hello game (Hello for Cancer). This game was modified to be better suited for individuals with cancer and their loved ones, and those modifications are now being tested. This game will include questions related to a variety of topics around an individual's cancer experience and medical decision making related to their cancer diagnosis.
After playing the game, individuals will be asked to reflect on the game questions and provide feedback to inform further modifications.
Group II: Table Topics gamePlacebo Group1 Intervention
For this arm, individuals will play commercially available Table Topics game during the research event. This game asks a variety of conversation starting questions, not particularly related to medical decision making.
Find a Location
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
504 Previous Clinical Trials
2,795,908 Total Patients Enrolled
Lauren Van Scoy, MDPrincipal InvestigatorPenn State College of Medicine
2 Previous Clinical Trials
107 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger